Marinus Pharmaceuticals GAAP EPS of -$0.42 in line, revenue of $8.54M down $0.81M Share this:FacebookX Related Post navigation Exclusive-US examining Russian accounts UBS acquired from Credit Suisse, sources say By Reuters Trump rally slows with stocks at record highs ahead of new economic data